Table 2.
Pharmacological history of AF patients with/out thyroid disorders.
| Variables | Total n (%) | AF/Thyroid disease n (%) | AF/no Thyroid disease n (%) | p-value | |
|---|---|---|---|---|---|
| Anticoagulants | .027 | ||||
| Use of anticoagulants | 1625 (81.3%) | 185 (88.1%) | 1440 (80.4%) | ||
| Vitamin K antagonist | 632 (31.6%) | 71 (33.8%) | 561 (31.3%) | ||
| Oral anticoagulants | 993 (49.7%) | 114 (54.3%) | 879 (49.1%) | ||
| Antiplatelets | |||||
| Use of antiplatelets | 925 (46.3%) | 81 (38.6%) | 844 (47.2%) | .019 | |
| Antiarrhythmics | |||||
| Beta blockers | 1603 (80.2%) | 168 (80%) | 1435 (80.2%) | .927 | |
| Amiodarone | 403 (20.2%) | 43 (20.5%) | 360 (20.1%) | .928 | |
| Calcium Channel Blockers | 199 (10.0%) | 23 (11.0%) | 176 (9.8%) | .626 | |
| Digoxin | 299 (15.0%) | 32 (15.2%) | 267 (14.9%) | .919 | |
| Others | |||||
| RAAS | 746 (37.3%) | 85 (40.5%) | 661 (36.9%) | .327 | |
| Diuretics | 759 (38.0%) | 77 (36.7%) | 666 (37.2%) | .051 | |
| Statins | 727 (36.4%) | 93 (44.3%) | 650 (36.3%) | .940 | |